In accordance with the data from TCGA, RBM8A was correlated with other genes that could be detected in adrenocortical carcinoma, breast invasive carcinoma, bladder carcinoma, breast invasive carcinoma, endometrial carcinoma, esophageal carcinoma, gastric carcinoma, glioblastoma, kidney clear cell carcinoma, lung adenocarcinoma, lower-grade glioma, lung squamous cell carcinoma, prostate carcinoma, and thyroid carcinoma (Figure 6). This evidence concerns the gene RBM8A and central nervous system cancer.